For breast cancer patients receiving adjuvant breast/chest wall RT + RNI, do you ever treat cervical nodes above the standard supraclavicular field (e.g., level II/III/V) when CT/MRI/PET is suspicious but biopsy is negative or non-diagnostic?
If yes, do you extend elective coverage and/or boost the dominant node, and what findings push you to treat as oligometastatic M1 instead?
For example, in a patient with ypN3a after NAC/ALND with an enhancing 1.6 cm ipsilateral SCV node and additional suspicious level II/III/V nodes on CT, PET read as reactive; FNA scant/atypical, core/excisional bx deemed too high risk.
What would be your field design and dose/fx recommendations?